gemcitabine

gemcitabine

 英

  • 网络吉西他滨;健择;健泽

例句

A recent phase III trial of the combination of gemcitabine with erlotinib was associated with a significant prolongation of survival .

最新III试验显示西联合尼布可以显著延长生存

Gemcitabine induced apoptosis and necrosis of purified MDSC in vitro in a time dependent manner.

西时间依赖性诱导MDSC凋亡坏死

This article briefly reviews the pharmacokinetics and mechanism of action of gemcitabine and its synergistic effect with platinum.

本文简要回顾药代动力学西作用机理及其协同作用

Gemcitabine is generally accepted as the standard chemotherapeutic agent for advanced pancreatic cancer.

西基础化疗胰腺主要治疗方法

The addition of erlotinib to gemcitabine shows a small but significant improvement in overall survival (OS) versus gemcitabine alone.

单独进行西治疗比较增加补充治疗结果显示所有存活OS获得一个但是明显改善

ObjectiveTo evaluate the efficacy, clinical benefits and toxicities of gemcitabine combined with erlotinib for advanced pancreatic cancer.

目的观察西联合方案治疗进展胰腺疗效临床获益反应毒性反应

Many pancreatic tumor cells are resistant to gemcitabine, which makes the disease very difficult to treat, explained Govindarajan.

很多胰腺肿瘤细胞西导致这种疾病现在很难得到有效治疗

Erlotinib is also being evaluated in combination with capecitabine in patients who failed first-line therapy with gemcitabine .

尼布联合他滨同样用于一线药物西治疗失败患者

An overview of the literature on the role of gemcitabine in the treatment of epithelial ovarian cancer is also presented.

一个西上皮卵巢治疗作用也是文学概要介绍

Patients could not have had prior chemotherapy with gemcitabine or cisplatin.

同时这些患者既往不能包含西或者顺铂化疗

Results In primary breast cancer, the antitumor effect of taxane is better than anthracycline and gemcitabine(P 0. 01).

复发乳腺癌患者西疗效明显优于蒽环类紫杉药物(P0。01)。

Objective: To evaluate the efficacy and toxicity of Gemcitabine for malignancy in the elderly.

目的评价西治疗老年人恶性肿瘤疗效副作用

Eligible patients were randomized to either treatment with gemcitabine alone (204 participants) or in combination with cisplatin (206).

这些满足适应症患者随机单用西(204和顺-西(206)。

After treatment with gemcitabine and CD40 antibody, the tumors shrank in 30% of the animals.

采用西CD40抗体治疗,30%肿瘤瘤缩小

The total yield of gemcitabine was 15. 8%.

结果合成盐酸西15.

Median survival for the combination therapy group reached 11. 7 months, compared with 8. 3 months for gemcitabine alone group (P = . 002).

联合治疗生存时间达到11.7个单用西只有8.3个(P=0.002)。

The HR was 0. 81 (p=0. 028), indicating a 19% reduction in the risk of death in patients treated with Tarceva plus gemcitabine.

危害HR0.81(p=0.028),表示接受特罗凯联合西治疗患者死亡危险降低19%。

AIM: To study the efficiency and toxicities of docetaxel gemcitabine combination on advanced non small cell lung cancer (NSCLC).

前言目的研究多西紫杉联合方案治疗晚期细胞肺癌NSCLC疗效

Trials on gemcitabine plus cisplatin semimonthly therapy versus that of triweekly therapy in advanced non-small-cell lung cancer

西联合顺铂周方案周方案治疗晚期细胞肺癌对比研究

Clinical study of gemcitabine with a sensitizer of concurrent radiotherapy in locally advanced non-small cell lung cancer

西增敏同期放疗局部晚期细胞肺癌临床观察

Pharmacokinetics study of gemcitabine and its metabolite in Chinese patients with malignant tumor

静脉注射西及其代谢产物人体药动学研究

Comparative study of cisplatin plus gemcitabine versus cisplatin plus vinorelbine in patients with advanced stage non-small cell lung cancer

西长春一线治疗晚期细胞肺癌对照研究

A Comparative Study of Gemcitabine plus Cisplatin and Gemcitabine plus Fluorouracil in Treating of Advanced Pancreatic Cancer

西联合顺铂尿嘧啶治疗晚期胰腺临床疗效比较

Experimental Study of Gemcitabine Intraocular Use in Inhibition of Posterior Capsule Opacification

西应用抑制白内障后后膜混浊实验研究

Comparative Study of Navelbine and Gemcitabine Regimen for Treatment of Patients with Old age Advanced Non-Small Cell Lung Cancer

长春瑞西方案治疗老年细胞肺癌对比研究

Clinical study of single gemcitabine or combination with cisplatin in treating senile advanced non-small cell lung cancer

西联合顺铂治疗高龄晚期细胞肺癌临床研究

Three dimensional-conformal radiotherapy combined with gemcitabine chemotherapy for locally advanced pancreatic cancers

三维适形放疗同步国产西化疗治疗局部晚期胰腺

Gemcitabine composed mainly of antineoplastic used for metastatic carcinoma of lung in 4 cases

西为主治疗转移4报告

Empirical Studies on Gemcitabine as a Mechanism of Radiosensitization in Human Nasopharyngeal Carcinoma Cell Line

鼻咽细胞放射增敏机制实验研究

Domestic or imported gemcitabine used in combination with cisplatin in the treatment of advanced non- small- cell lung cancer

国产进口西联合顺铂治疗细胞肺癌疗效副作用观察

Combination of gemcitabine intravenous injection and cisplatin peritoneal perfusion for biliary malignancies

联合腹腔灌注治疗恶性肿瘤临床研究

Survivin antisense oligonucleotide induces apoptosis and sensitizes pancreatic cancer cells to Gemcitabine

Survivin反义核苷酸诱导胰腺癌细胞凋亡增加西化疗敏感性

Comparative study of vinorelbine and gemcitabine in the treatment of advanced non-small cell lung cancer

西长春治疗晚期细胞肺癌比较研究

Research on gemcitabine combined cisplatin peritoneal perfusion in the treatment of primary hepatocellular carcinoma

联合腹腔灌注顺铂治疗原发性肝细胞临床研究

Therapeutic effects of gemcitabine regional artery perfusion combined with systemic chemotherapy for late-stage cancer of pancreas

西区域性动脉灌注联合全身化疗治疗晚期胰腺

The clinical study of domestic gemcitabine combined cisplatine in treatment of 29 patients with advanced non-small cell lung cancer

国产西联合顺铂治疗晚期细胞肺癌29临床观察

Gemcitabine combined with irinotecan as first-line therapy for advanced pancreatic cancer: A Meta-analysis of randomized controlled trials

西联合伊立一线治疗晚期胰腺随机对照试验Meta分析

The Clinical Observation of the Treatment of Advanced Non-Small Cell Lung Cancer with Gemcitabine plus Platinum Complexes

西联合铂类化疗药物治疗晚期细胞肺癌临床观察

Treatment of advanced pancreatic carcinoma by gemcitabine arterial infusion chemotherapy

动脉灌注治疗晚期胰腺

A comparing trial of gemcitabine plus carboplatin versus etoposide plus carbo latin in treatment of patients with advanced esophageal cancer

西依托泊治疗晚期食管癌对照试验